STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLNO
  4. [SCHEDULE 13G] Soleno Therapeutics, Inc. SEC Filing

[SCHEDULE 13G] Soleno Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SLNO logo
Soleno Therapeutics Inc

NASDAQ:SLNO

SLNO Rankings

#2710 Ranked by Market Cap
N/A Ranked by Dividends

SLNO Latest News

Jul 10, 2025
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Jul 10, 2025
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
Jul 10, 2025
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
Jul 1, 2025
Soleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ENDO 2025
Jun 25, 2025
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference

SLNO Latest SEC Filings

Jul 10, 2025
[8-K] Soleno Therapeutics, Inc. Reports Material Event
Jul 10, 2025
[424B5] Soleno Therapeutics, Inc. Prospectus Supplement (Debt Securities)
Jul 3, 2025
[Form 4] Soleno Therapeutics, Inc. Insider Trading Activity
Jul 1, 2025
[144] Soleno Therapeutics, Inc. SEC Filing
Jun 26, 2025
[Form 4] Soleno Therapeutics, Inc. Insider Trading Activity

SLNO Stock Data

4.37B
47.40M
2.93%
113.72%
10.48%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States
REDWOOD CITY